MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CRNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Crinetics Pharmaceuticals (CRNX) Earnings Date & Reports

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more

A.I. Advisor
published Earnings

CRNX is expected to report earnings to fall 5.69% to -115 cents per share on November 06

Crinetics Pharmaceuticals CRNX Stock Earnings Reports
Q3'25
Est.
$-1.16
Q2'25
Missed
by $0.13
Q1'25
Missed
by $0.11
Q4'24
Est.
$-0.88
Q3'24
Missed
by $0.05
The last earnings report on August 07 showed earnings per share of -123 cents, missing the estimate of -110 cents. With 296.33K shares outstanding, the current market capitalization sits at 2.58B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CRNX
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For CRNX
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRNX showed earnings on August 07, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com